- ASSOCIATE PROFESSOR (PENDING) Medicine, Gastroenterology
American Board of Internal Medicine
MD, UMDNJ Robert Wood Johnson Medical School
Residency, Internal Medicine
NYU Medical Center
University of California - San Francisco
- 1. New York University-BA with Honors in Biology, 1990
2. UMDNJ-Robert Wood Johnson Medical School-MD, 1994
3. N.Y.U. Medical Center- Residency in Internal Medicine, 1994-1997
4. N.Y.U. Medical Center- Chief Medical Resident, 1997-1998
5. University of California, San Francisco-Gastroenterology Fellowship, 1999-2002
6. University of California, Berkeley-Master in Public Health, 2003
Honors • 2004 Academic Skills Workshop Participant, American Gastroenterological Association • 2003 Cancer Research and Prevention Foundation Fellowship Award • 2001 American College of Gastroenterology Clinical Research Award • 1992 NIH Summer Student Fellowship • 1990 Horace W. Stunkard Prize, New York University • 1986-1990 College of Arts and Science Scholar, New York University • 1986-1990 Dean’s Fellow, New York University
New topic1. Pancreatic Cancer
2. Esophageal Cancer
3. Colon Cancer
4. Gastroesophageal Reflux Disease
5. Therapeutic Endoscopy
8. Enteral Stenting
Siba Y, Gorantla S, Gupta A, Lung E, Culpepper-Morgan J. Esophageal intramural pseudodiverticulosis, a rare cause of food impaction: case report and review of the literature. Gastroenterology report 2015 May; 3(2).
Velayos FS, Williamson A, Sousa KH, Lung E, Bostrom A, Weber EJ, Ostroff JW, Terdiman JP. Early predictors of severe lower gastrointestinal bleeding and adverse outcomes: a prospective study. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2004 Jun; 2(6).
Teng A, Haas C, Lee DY, Wang J, Lung E, Attiyeh F. Primary lymph node gastrinoma. A diagnosis of exclusion. A case for duodenotomy in the setting of a negative imaging for primary tumor: A case report and review of the literature. International journal of surgery case reports 2014 Oct; 5(11).
Lung E. Diagnosis of Irritable Bowel Syndrome. The Gastroenterology Fellow 2003;2:2-9..;.
Lung E. Evaluation and Management of Gastrointestinal Bleeding, Part One: Upper GI Bleeding. Advanced Studies in Medicine. 2004;4(4):186-190..;.
Lung E. Evaluation and Management of Gastrointestinal Bleeding, Part Two: Lower GI Bleeding and Obscure GI Bleeding. Advanced Studies in Medicine. 2004;4(5):245-250..;.
Lung E. Acute Diarrheal Diseases. In Current Diagnosis & Treatment In Gastroenterology, 2nd edition. Edited by Grendell JH, McQuaid KR, and Friedman SL..;.
Lung E, Levin TR, Habel L, Corley D. Prevalence of gastric metaplasia without intestinal metaplasia among patients with adenocarcinoma of the esophagus. Gastrointestinal Endoscopy 2001;53:AB146. Presented at Digestive Disease Week, May 2001..;.
Velayos FS, Lung E, Bostrom A, Weber E, Ostroff JW, Terdiman JP. Early predictors of significant lower intestinal bleeding and adverse events: A prospective study. Presented at the 68th Annual Scientific Meeting of the American College of Gastroenterology, October, 2003..;.
Lung E, . The Effect of Rofecoxib on Cyclooxygenase-2 Expression, Prostaglandin E2 Content, and Cell Proliferation in Barrett’s Esophagus. Presented at American Gastroenterological Association Poster Session, Digestive Disease Week, May 2004..;.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Lung did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
36 W. 60th St
New York, NY 10023